134 related articles for article (PubMed ID: 16594663)
1. Unexpected deacetylation mechanism suggested by a density functional theory QM/MM study of histone-deacetylase-like protein.
Corminboeuf C; Hu P; Tuckerman ME; Zhang Y
J Am Chem Soc; 2006 Apr; 128(14):4530-1. PubMed ID: 16594663
[TBL] [Abstract][Full Text] [Related]
2. Theoretical study revealing the functioning of a novel combination of catalytic motifs in histone deacetylase.
Vanommeslaeghe K; De Proft F; Loverix S; Tourwé D; Geerlings P
Bioorg Med Chem; 2005 Jun; 13(12):3987-92. PubMed ID: 15878665
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylases--an important class of cellular regulators with a variety of functions.
Hildmann C; Riester D; Schwienhorst A
Appl Microbiol Biotechnol; 2007 Jun; 75(3):487-97. PubMed ID: 17377789
[TBL] [Abstract][Full Text] [Related]
4. Quantum polarized ligand docking investigation to understand the significance of protonation states in histone deacetylase inhibitors.
Kalyaanamoorthy S; Chen YP
J Mol Graph Model; 2013 Jul; 44():44-53. PubMed ID: 23732305
[TBL] [Abstract][Full Text] [Related]
5. Quantum chemical study on the coordination environment of the catalytic zinc ion in matrix metalloproteinases.
Díaz N; Suarez D; Sordo TL
J Phys Chem B; 2006 Nov; 110(47):24222-30. PubMed ID: 17125395
[TBL] [Abstract][Full Text] [Related]
6. Zinc binding in HDAC inhibitors: a DFT study.
Wang D; Helquist P; Wiest O
J Org Chem; 2007 Jul; 72(14):5446-9. PubMed ID: 17579460
[TBL] [Abstract][Full Text] [Related]
7. Computational study of the phosphoryl transfer catalyzed by a cyclin-dependent kinase.
De Vivo M; Cavalli A; Carloni P; Recanatini M
Chemistry; 2007; 13(30):8437-44. PubMed ID: 17636466
[TBL] [Abstract][Full Text] [Related]
8. Zn(II)-dependent histone deacetylase inhibitors: suberoylanilide hydroxamic acid and trichostatin A.
Codd R; Braich N; Liu J; Soe CZ; Pakchung AA
Int J Biochem Cell Biol; 2009 Apr; 41(4):736-9. PubMed ID: 18725319
[TBL] [Abstract][Full Text] [Related]
9. Structural biology of human metal-dependent histone deacetylases.
Schapira M
Handb Exp Pharmacol; 2011; 206():225-40. PubMed ID: 21879452
[TBL] [Abstract][Full Text] [Related]
10. Comparative molecular dynamics simulations of histone deacetylase-like protein: binding modes and free energy analysis to hydroxamic acid inhibitors.
Yan C; Xiu Z; Li X; Li S; Hao C; Teng H
Proteins; 2008 Oct; 73(1):134-49. PubMed ID: 18398905
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the two catalytic domains in histone deacetylase 6.
Zou H; Wu Y; Navre M; Sang BC
Biochem Biophys Res Commun; 2006 Mar; 341(1):45-50. PubMed ID: 16412385
[TBL] [Abstract][Full Text] [Related]
12. A QM/QM investigation of the hUNG2 reaction surface: the untold tale of a catalytic residue.
Przybylski JL; Wetmore SD
Biochemistry; 2011 May; 50(19):4218-27. PubMed ID: 21473605
[TBL] [Abstract][Full Text] [Related]
13. How does the cAMP-dependent protein kinase catalyze the phosphorylation reaction: an ab initio QM/MM study.
Cheng Y; Zhang Y; McCammon JA
J Am Chem Soc; 2005 Feb; 127(5):1553-62. PubMed ID: 15686389
[TBL] [Abstract][Full Text] [Related]
14. Exploration of the internal cavity of histone deacetylase (HDAC) with selective HDAC1/HDAC2 inhibitors (SHI-1:2).
Methot JL; Chakravarty PK; Chenard M; Close J; Cruz JC; Dahlberg WK; Fleming J; Hamblett CL; Hamill JE; Harrington P; Harsch A; Heidebrecht R; Hughes B; Jung J; Kenific CM; Kral AM; Meinke PT; Middleton RE; Ozerova N; Sloman DL; Stanton MG; Szewczak AA; Tyagarajan S; Witter DJ; Secrist JP; Miller TA
Bioorg Med Chem Lett; 2008 Feb; 18(3):973-8. PubMed ID: 18182289
[TBL] [Abstract][Full Text] [Related]
15. Nuclear histone deacetylases are not required for global histone deacetylation during meiotic maturation in porcine oocytes.
Endo T; Kano K; Naito K
Biol Reprod; 2008 Jun; 78(6):1073-80. PubMed ID: 18305223
[TBL] [Abstract][Full Text] [Related]
16. Probing the elusive catalytic activity of vertebrate class IIa histone deacetylases.
Jones P; Altamura S; De Francesco R; Gallinari P; Lahm A; Neddermann P; Rowley M; Serafini S; Steinkühler C
Bioorg Med Chem Lett; 2008 Mar; 18(6):1814-9. PubMed ID: 18308563
[TBL] [Abstract][Full Text] [Related]
17. Development of histone deacetylase inhibitors for cancer treatment.
Marchion D; Münster P
Expert Rev Anticancer Ther; 2007 Apr; 7(4):583-98. PubMed ID: 17428177
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylation as a target for radiosensitization.
Cerna D; Camphausen K; Tofilon PJ
Curr Top Dev Biol; 2006; 73():173-204. PubMed ID: 16782459
[TBL] [Abstract][Full Text] [Related]
19. Acetylation of Sirt2 by p300 attenuates its deacetylase activity.
Han Y; Jin YH; Kim YJ; Kang BY; Choi HJ; Kim DW; Yeo CY; Lee KY
Biochem Biophys Res Commun; 2008 Oct; 375(4):576-80. PubMed ID: 18722353
[TBL] [Abstract][Full Text] [Related]
20. HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics.
Gallinari P; Di Marco S; Jones P; Pallaoro M; Steinkühler C
Cell Res; 2007 Mar; 17(3):195-211. PubMed ID: 17325692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
